Therapeutic efficacy of hepatitis B surface antigen-antibodies-recombinant DNA composite in HBsAg transgenic mice

By Zheng B.-J.   Ng M.-H.   He L.-F.   Yao X.   Chan K.-W.   Yuen K.-Y.   Wen Y.-M.  

Vaccine, Vol. 19, Iss. 30, 2001-07 ,pp. : 4219-4225

Elsevier

Access to resources Recommend Favorite

Vaccination with ubiquitin-hepatitis B core antigen-cytoplasmic transduction peptide enhances the hepatitis B virus-specific cytotoxic T-lymphocyte immune response and inhibits hepatitis B virus replication in transgenic mice

By                

Molecular Medicine Reports, Vol. 12, Iss. 3, 2015-01 ,pp. : 3591-3598

Spandidos Publications

Access to resources Recommend Favorite

In VivoInduction of Specific Cytotoxic T Lymphocytes in Mice and Rhesus Macaques Immunized with DNA Vector Encoding an HIV Epitope Fused with Hepatitis B Surface Antigen

By Le Borgne S.   Mancini M.   Le Grand R.   Schleef M.   Dormont D.   Tiollais P.   Riviere Y.   Michel M.-L.  

Virology, Vol. 240, Iss. 2, 1998-01 ,pp. : 304-315

Elsevier

Access to resources Recommend Favorite

DNA-based immunization against hepatitis B surface antigen (HBsAg) in normal and HBsAg-transgenic mice

By Davis H.L.   Millan C.L.B.   Mancini M.   McCluskie M.J.   Hadchouel M.   Comanita L.   Tiollais P.   Whalen R.G.   Michel M.-L.  

Vaccine, Vol. 15, Iss. 8, 1997-06 ,pp. : 849-852

Elsevier

Access to resources Recommend Favorite

HBsAg/HLA-A2 transgenic mice: a model for T cell tolerance to hepatitis B surface antigen in chronic hepatitis B virus infection

By Loirat D.  

International Immunology, Vol. 15, Iss. 10, 2003-10 ,pp. : 1125-1136

Oxford University Press

Access to resources Recommend Favorite